Sorrento Therapeutics Inc Bounce Off 61.8 Percent Retracement

Sorrento Therapeutics Inc has bounced off its 61.8 percent Fibonacci retracement level.

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

Global Blood Therapeutics Rising Large Players Volume

Global Blood Therapeutics stock has excellent large players volume action. Large players volume is in an uptrend and is confirmed by the rising Twiggs Money Flow.

Global Blood Therapeutics stock has 11 Buy ratings from analysts. Price targets average to $55.73 which represents 71.73% upside from the previous closing price. Needham & Company, one of the most followed analyst firms because of their excellent record, set a price target on the stock today of $51 which is 57% upside from the previous close at $32.45.

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

Mannkind Corporation Stock 38.2 Percent Retracement On Analyst Buy

Mannkind Corporation stock has done a 38.2 percent Fibonacci Retracement on a new Buy rating on the stock. HC Wainwright picked up coverage of the stock and issued a Buy rating on Tuesday, October 10, 2017.

Mannkind stock also has insider buying. Director Kent Kresa purchased 166,600 shares of the firm's stock in a transaction on Friday, October 13th. The stock was bought at an average cost of $6.00 per share, with a total value of $999,600.00.

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

Aurinia Pharmaceuticals Gets Buy Rating From Seaport Global Securities

On Friday, October 7, 2017, Aurinia Pharmaceuticals received a Buy rating from Seaport Global Securities. Seaport Global set a $10.00 price target on the stock which is 52.4% upside from the previous close of $6.56.

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

Sell Catalyst Pharmaceuticals For a 47% Gain

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

Sell Portola Pharmaceuticals For a 45% Win!

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

Jazz Pharmaceuticals Announces Positive Results From Phase 3 TONES 3 and TONES 4

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

Sell Global Blood Therapeutics For a Huge 91% Win!

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

CRISPR’s Brave New World

Just a handful of technologies deserve to be called “game changers”—and CRISPR-Cas9, the new gene-editing tool, is one of them. Discovered just three years ago, CRISPR is sweeping through labs around the world and researchers are already using it to experiment on diseases like cancer and AIDS, engineer new sources of clean energy, and create hardier plants and animals with the goal of wiping out world hunger. This Salon gathers bioengineers and medical researchers to take a hard look at the monumental changes hovering on the horizon.

Salon: Game Change – CRISPR’s Brave New World

The Big Ideas Series is supported in part by the John Templeton Foundation. Additional support provided by The Jackson Laboratory.

Subscribe to our YouTube Channel for all the latest from WSF.
Visit our Website: http://www.worldsciencefestival.com/
Like us on Facebook: https://www.facebook.com/worldsciencefestival
Follow us on twitter: https://twitter.com/WorldSciFest

Original Program Date: June 4, 2016
MODERATOR: Robert Benezra
PARTICIPANTS: Ellen Jorgensen, Ben Matthews, Neville Sanjana, Jacob S. Sherkow, Stephen Tsang

Robert Benezra Introduction 00:05

Participant Introductions 00:57

How was CRISPR discovered? 3:31

Is it surprising how quickly CRISPR has been embraced? 8:34

What are the significant ways scientists are using CRISPR? 12:25

Do we want to manipulate the human genome? 22:50

What are the ethics that come with CRISPR? 30:17

How would we release a gene drive into the world 35:22

The first retinal gene therapy trial 41:44

Can CRISPR be used to replace dopaminergic neurons? 49:07

As CRISPR becomes more available could it suffer from under or over regulation? 1:00:47

How much can CRISPR cost? 1:06:25

Will CRISPR be the breakthrough for treating disorders? 1:17:36

Wells Fargo Gives Buy On Juno One Day, Downgrades the Next!

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.